热门资讯> 正文
阿尔托神经科学任命迈克尔·汉利为首席运营官
2024-05-21 20:21
- Alto Neuroscience (NYSE:ANRO) said it has appointed industry veteran Michael Hanley as chief operating officer.
- Hanley has over 25 years of leadership experience in the life sciences industry, and most recently served as chief commercial officer and chief business officer at Aeglea BioTherapeutics.
More on Alto Neuroscience
- Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders
- Alto Neuroscience schizophrenia treatment shows good phase 1 results
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
